investors.

CSE: MOOD | FSE: VU7 | OTC: DOSEF

Doseology Sciences Inc. is building a progressive brand focused on mental health and wellness through cultivation, extraction and innovative nutraceutical and pharmaceutical products. Doseology aims to make a meaningful impact on the mental health pandemic by utilizing and developing plant-derived drugs and functional fungi. With a vertically integrated approach, Doseology intends to process and distribute products at its facilities in Vernon, British Columbia, in accordance with applicable laws to ensure safe and high-quality production.

corporate team

Ralph Olson

INTERIM CEO,
DIRECTOR

Ralph is an experienced private investor and was influential in raising $400 million for both public and private companies. He was a Partner with Global Capital Partners and helped execute the merger with Cohig and Associates. He has a Finance degree from the University of Washington.

Peter Geh

CFO


Peter takes pride in his hands-on approach to financial management. As a Chartered Professional Accountant (CPA) with over 15 years of accounting and financial experience, he has guided several Canadian companies through growth stages in the technology, retail, and manufacturing industries.

Scott Reeves

DIRECTOR,
CORPORATE COUNSEL

Scott has 20+ years focused on securities, corporate finance, M&A and commercial transactions. In addition to serving on several TSX and TSX Venture exchange across multiple industries, Scott is also a partner at Tingle Merrett LLP in Calgary. He is Past Chairman and Member of the Canadian Bar Association, Calgary Bar and Law Society of Alberta.

Harbir Thoor

DIRECTOR,
INDEPENDENT AUDIT CHAIR

Harbir (CPA, CA) has 25 years of experience in strategic planning, risk management, governance, capital raises, and financial accounting. She began her career in audit at KPMG and most recently has held several senior executive positions in both private and publicly listed companies, including VP Finance and CFO in the biopharmaceutical and life sciences industries.

Daniel Vice

DIRECTOR


Daniel brings advanced knowledge in pharmacotherapeutics, neuroscience, and psychiatry to Doseology. He is passionate about an integrative approach to mental health, including evidence-based treatments with the goal of achieving the best health outcomes for individuals. He received his Master's degree in nursing from Johns Hopkins University and is a psychiatric nurse practitioner doctoral student at the University of Missouri.

advisors

Dr. Basin

CHIEF MEDICAL OFFICER

Dr. Bhasin is a board-certified anesthesiologist with over 25 years of experience. He is the owner and operator of PointKetamine clinics located around the Los Angeles area and is affiliated with numerous hospitals in California, including the University of Southern California Medical Center.

Timi Wood

BIOTECHNOLOGIST 

Timi is a plant and fungi Biotechnologist with a bias on mushroom production and research. He has over 12 years work experience on Mushroom R&D and spawn production. He is a Chief Scientific officer at the National Biotechnology Development Agency, Nigeria, coordinating Mushroom Research and Development programs. He is a certified mushroom spawn developer with the Institute of Edible Fungi, Shanghai, China.

Oliver Wellman-Labadie

QPIC

Dr. Wellman-Labadie, Ph.D. has been serving as an Advisor to Doseology and is the Qualified Person in Charge (QPIC) for the Company’s Controlled Drugs and Substances Dealer’s Licence application. In his role as the QPIC, he will perform the duties required by the Health Canada Controlled Drugs and Substances Dealer’s L i cence , and contribute to the development of psilocybin research and mushroom production. He holds a Doctorate in Molecular Biology from The University of Ottawa (2008), and an MBA with specialization in Pharmaceutical Marketing and Management f rom Universite Laval (2009). 

regulatory filings

corporate directory

DOSEOLOGY FACILITY

Legal Counsel
Tingle Merrett LLP.
www.tinglemerrett.com

Auditor
Dale Matheson Carr-Hilton Labonte LLP
www.dmcl.ca

Transfer Agent
Endeavor Trust Corporation
www.endeavourtrust.com

read the latest investor news